Ledger.Open graph →
SEC Form D · Amendment · filed June 5, 2013

Reven Pharmaceuticals, Inc

Offering
$2.0M
Sold
$526K
Exemption
—
Industry
Pharmaceuticals
Location
SARASOTA, FL
Type
—

People & firms on this filing (3)

Edward M. Hundert · New York, NYExec · DirectorJeffrey R. Brown · New York, NYExec · DirectorTeresa K. Hassara · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗